Management of Xanthelasma at Chaha Eye Hospitals Kaduna- A Case Report

  • Home
  • Management of Xanthelasma at Chaha Eye Hospitals Kaduna- A Case Report

Management of Xanthelasma at Chaha Eye Hospitals Kaduna- A Case Report

1*Chaha K, 2Ajike S.O
1Chaha Eye Hospitals, Kaduna Nigeria
2Maxilo-facial Unit, Ahmadu Bello Teaching Hospital, Shika Zaria, Nigeria.
 
ABSTRACT

Many systemic conditions have eye manifestations which are often the earliest signs to give out such conditions. Xanthelasmas are such eye conditions that are commonly treated primarily as eye conditions; overlooking the systemic associations which are more life threatening. The aim of these reports is to highlight the systemic associations of ocular xanthelasmas and the management modalities of the condition.

 
KEYWORDS

Xanthelasma, Systemic, Associations

 
REFERENCES

1) Boon NA.; Colledge NR; Brian R. Walker BR: Xanthomas; Davidson’s Principles and Practice of Medicine, 20th Edition, Chapter 27,pp 1308 
2) Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum, Journal of the American Academy of Dermatology Volume 30, Issue 2 , Pages 236-242, February 1994
3) Wikipedia the free encyclopedias: Xanthelasma
4) Nelson LB, Olitsky SE: Harley’s Pediatric Ophthalmology 5th Edition, Chapter,pp 380
5) Fair KP, Elston DM :Medicine.medscape.com/article/1103971
6) Robinson RCV: Treatment of Xanthelasma with Vitamin B12 : The Journal of Investigative Dermatology (1955)24, 111-113;doi:10.1038/jid.1955.18
7) Shields C L, Mashayekhi A, Shields J A, and Racciato P. .Disappearance of eyelid xanthelasma following oral simvastatin (Zocor) Br J Ophthalmol. 2005 May; 89(5): 639–640.
8) Lee H Y, Jin U S, Minn K W. Outcomes of Surgical Management of Xanthelasma Palpebrarum. Arch Plast Surg. 2013 Jul; 40(4): 380–386. Published online 2013 Jul 17. doi:10.5999/aps. 2013.40(4): 380-386. PMCID: PMC3723999
9) Haygood LJ, Bennett JD, Brodell RT. Treatment of xanthelasma palpebrarum with bichloracetic acid. Dermato Surg. 1998 Sept; 24(9):1027-31
10) Xanthelasma: my.clevelandclinic.org/health/disease/23385-xanthelasma
11) Rapid resolution of xanthelasmas after treatment with alirocumab. Fernando Civeira , Sofia Perez-Calahorra, Rocio Mateo-Gallego Journal of Clinical Lipidology. Volume 10, Issue 5, September–October 2016, Pages 1259-126. 1

https://doi.org/10.1016/j.jacl.2016.07.007
12)https://www.nhs.uk/medicines/statins/side-effects/#:~:text=headache,low%20 blood%20platelet%20count

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *